Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Last data update: Jul 03, 2022. (Total: 48007 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 30 Records)

Next

Query Trace: Cardiomyopathy[original query]>>Evidence Synthesis [Product Type]
Arrhythmogenic Right Ventricular Cardiomyopathy Prevalence and Arrhythmic Outcomes in At-Risk Family Members: A Systematic Review and Meta-Analysis.
Sharma Apurva et al. Circulation. Genomic and precision medicine 2022 101161CIRCGEN121003530
A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review.
Chung Liang Lam et al. Frontiers in bioengineering and biotechnology 2022 10833833
Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis.
Christian Susan et al. Open heart 2022 9(1)
Comprehensive Analysis of Genes Associated With Sudden Infant Death Syndrome.
Mehboob Riffat et al. Frontiers in pediatrics 2021 9742225
Cascade health service use in family members following genetic testing in children: a scoping literature review.
Cernat Alexandra et al. European journal of human genetics : EJHG 2021
Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy.
Rozenbaum Mark H et al. Journal of comparative effectiveness research 2021
An Evidence-Based Assessment of Genes in Dilated Cardiomyopathy.
Jordan Elizabeth et al. Circulation 2021
An Integrated Review of Hypertrophic Cardiomyopathy in Black Populations: Underrecognized and Understudied.
Arabadjian Milla et al. The Journal of cardiovascular nursing 36(2) 104-115
Angiotensinogen M235T polymorphism and susceptibility to hypertrophic cardiomyopathy in Asian population: A meta analysis.
Zhen Zhen et al. Journal of the renin-angiotensin-aldosterone system : JRAAS 21(4) 1470320320978100
Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review.
Fraser Hannah et al. Orphanet journal of rare diseases 2019 Nov 14(1) 258
CLINGEN Actionability Report for Dilated cardiomyopathy - DMD, LMNA, TNNT2
ClinGen Actionability Working Group
CLINGEN Actionability Report for Fabry Disease - GLA
ClinGen Actionability Working Group
CLINGEN Actionability Report for Glycogen Storage Disease 2 - GAA
ClinGen Actionability Working Group
CLINGEN Actionability Report for Familial Hypertrophic Cardiomyopathy - ACTC1, CSRP3, MYBPC3, MYH7, MYL2, MYL3, PRKAG2, TNNI3, TNNT2, TPM1
ClinGen Actionability Working Group
CLINGEN Actionability Report for Hemochromatosis, Type 1-HFE
ClinGen Actionability Working Group
CLINGEN Actionability Report for Catecholaminergic Polymorphic Ventricular Tachycardia - RYR2
ClinGen Actionability Working Group
CLINGEN Actionability Report for Very Long Chain Actyl-CoA Dehydrogenase Deficiency (ACADVLD) - ACADVL
ClinGen Actionability Working Group
CLINGEN Actionability Report for Emery-Dreifuss Muscular Dystrophy (AD, XL) - LMNA, EMD, FHL1
ClinGen Actionability Working Group
CLINGEN Actionability Report for Hereditary transthyretin-related amyloidosis - TTR
ClinGen Actionability Working Group
CLINGEN Actionability Report for Myofibrillar Myopathy -DES, BAG3, FLNC
ClinGen Actionability Working Group
CLINGEN Actionability Report for Glycogen Storage Disease V - PYGM
ClinGen Actionability Working Group
CLINGEN Actionability Report for Arrhythmogenic Right Ventricular Dysplasia - PKP2, DSP, DSC2, TMEM43, DSG2
ClinGen Actionability Working Group
A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy.
Catchpool Max et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Jun
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
Ingles Jodie et al. Circulation. Genomic and precision medicine 2019 Jan
Cost Efficacy of ?-Galactosidase A Enzyme Screening for Fabry Disease.
Newman Darrell B et al. Mayo Clinic proceedings 2019 Jan 94(1) 84-88
Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review.
Naik Rakhi P, et al. Annals of internal medicine 2018 11 0. (9) 619-627
Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.
Prosser Lisa A et al. MDM policy & practice 3(1)
Next Generation DNA Sequencing: A Review of the Cost Effectiveness and Guidelines
Clinical utility gene card for: arrhythmogenic right ventricular cardiomyopathy (ARVC).
Clinical utility gene card for: dilated cardiomyopathy (CMD).
TOP